BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,639,300 | -43.2% | 1,690,000 | -42.5% | 0.12% | -38.1% |
Q2 2023 | $2,887,868 | -4.3% | 2,940,000 | 0.0% | 0.20% | -14.0% |
Q1 2023 | $3,016,378 | -3.3% | 2,940,000 | 0.0% | 0.23% | -16.1% |
Q4 2022 | $3,120,222 | +7.1% | 2,940,000 | 0.0% | 0.27% | +1.1% |
Q3 2022 | $2,913,000 | +20.6% | 2,940,000 | +20.5% | 0.27% | +18.4% |
Q2 2022 | $2,416,000 | +449.1% | 2,440,000 | +454.5% | 0.23% | +635.5% |
Q1 2022 | $440,000 | -95.2% | 440,000 | -94.9% | 0.03% | -94.6% |
Q4 2021 | $9,097,000 | +61.6% | 8,700,000 | +58.2% | 0.58% | +40.1% |
Q3 2021 | $5,628,000 | +61.1% | 5,500,000 | +65.2% | 0.41% | +8.7% |
Q3 2020 | $3,494,000 | -14.1% | 3,330,000 | 0.0% | 0.38% | -54.2% |
Q2 2020 | $4,069,000 | +22.3% | 3,330,000 | +4.9% | 0.83% | +27.5% |
Q1 2020 | $3,327,000 | – | 3,175,000 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERBACK ASSET MANAGEMENT LLC | 36,000,000 | $36,583,000 | 5.85% |
Man Investments (CH) AG | 3,200,000 | $3,250,000 | 2.78% |
Verde Servicos Internacionais S.A. | 11,000,000 | $11,165,000 | 2.06% |
Jabre Capital Partners S.A. | 10,000,000 | $10,156,000 | 1.97% |
LINDEN ADVISORS LP | 38,500,000 | $39,095,000 | 1.39% |
Opera Trading Capital | 9,900,000 | $9,925,000 | 1.35% |
Sonora Investment Management, LLC | 4,950,000 | $5,029,596,000 | 0.87% |
CQS Cayman LP | 10,000,000 | $10,165,000 | 0.68% |
Polar Asset Management Partners Inc. | 25,000,000 | $25,384,000 | 0.51% |
ADVENT CAPITAL MANAGEMENT /DE/ | 26,000,000 | $26,383,000 | 0.50% |